Pharmaco - Press Releases

Date	Title	Company
16-Dec-2021	Biophytis to meet with FDA to advance Sarconeos (BIO101) development in Sarcopenia from Phase 2 to Phase 3	Biophytis
16-Dec-2021	Zur Rose and the Swiss Association for the Blind and Visually Impaired make it easier for people with a visual impairment to take medication	Zur Rose Group AG
16-Dec-2021	Evotec receives US$ 18 m grant for women's health	Evotec SE
16-Dec-2021	APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO	APONTIS PHARMA AG
16-Dec-2021	Straumann Group presents evolved strategy to achieve its long-term revenue ambition of CHF 5 billion	Straumann Holding AG
16-Dec-2021	Relief Therapeutics Files Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission	RELIEF THERAPEUTICS Holding AG
15-Dec-2021	Abivax to present at the J.P. Morgan 40th Annual Healthcare Conference	ABIVAX
15-Dec-2021	Vita 34 presents itself in new size for the first time at the Annual General Meeting 2021	Vita 34 AG
15-Dec-2021	OncoHost Announces Collaboration with Heidelberg University’s Lung Research Biobank to Discover Lung Cancer Biomarkers	OncoHost
15-Dec-2021	Sartorius and HOF Sonderanlagenbau Partnership Creates Streamlined Offering of Freeze-Thaw Solutions for Biological Products	Sartorius
15-Dec-2021	OMass Founder, Professor Dame Carol Robinson, Honoured with the 2022 Louis-Jeantet Prize for Medicine and the 2022 Benjamin Franklin Medal in Chemistry	OMass Therapeutics
15-Dec-2021	Scientists reveal how the body controls allergy-causing immune cells	Francis Crick Institute
15-Dec-2021	Nanopharm Announces Expansion to Enable Full Services Solutions to Meet Increasing Customer Needs	Nanopharm
15-Dec-2021	Clasado steps up GPA engagement with executive board and committee appointments	Clasado
15-Dec-2021	Oxford Spin-out Alethiomics launches to advance its multi-omics target discovery pipeline in blood cancer, as highlighted in ASH plenary	Alethiomics
15-Dec-2021	SciRhom Establishes a World-Class Clinical Advisory Board	SciRhom GmbH
15-Dec-2021	A year of international growth and product advancement	Biocomposites
15-Dec-2021	GW Pharmaceuticals receives approval for the reimbursement of Epidyolex® (cannabidiol) for the treatment of seizures associated with Tuberous sclerosis complex in Wales	GW Pharmaceuticals
15-Dec-2021	Sareum receives ‘Intention to Grant’ Notification from the European Patent Office for its TYK2/JAK1 inhibitor SDC-1802	Sareum
15-Dec-2021	Transgene announces License Option Exercise by AstraZeneca for an Oncolytic Virus Generated by Transgene’s Invir.IO™ Platform	Transgene